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ARTICLE OPEN
Health worker and patient views on implementation of
smoking cessation in routine tuberculosis care
Melanie Boeckmann 1,2,3, Sahil Warsi 4, Maryam Noor5, Omara Dogar2, Esha Haowa Mustagﬁra6, Fariza Firoze7, Raana Zahid5,
Anne Readshaw2, Kamran Siddiqi2, Daniel Kotz 1,8,9 and the TB & Tobacco Consortium
Smoking worsens tuberculosis (TB) outcomes. Persons with TB who smoke can beneﬁt from smoking cessation. We report ﬁndings
of a multi-country qualitative process evaluation assessing barriers and facilitators to implementation of smoking cessation
behaviour support in TB clinics in Bangladesh and Pakistan. We conducted semi-structured qualitative interviews at ﬁve case study
clinics with 35 patients and 8 health workers over a period of 11 months (2017–2018) at different time points during the
intervention implementation phase. Interviews were conducted by trained researchers in the native languages, audio-recorded,
transcribed into English and analysed using a combined deductive–inductive approach guided by the Consolidated Framework for
Implementation Research and Theoretical Domains Framework. All patients report willingness to quit smoking and recent quit
attempts. Individuals’ main motivations to quit are their health and the need to ﬁnancially provide for a family. Behavioural
regulation such as avoiding exposure to cigarettes and social inﬂuences from friends, family and colleagues are main themes of the
interviews. Most male patients do not feel shy admitting to smoking, for the sole female patient interviewee stigma was an issue.
Health workers report structural characteristics such as high workload and limited time per patient as primary barriers to offering
behavioural support. Self-efﬁcacy to discuss tobacco use with women varies by health worker. Systemic barriers to implementation
such as staff workload and socio-cultural barriers to cessation like gender relations, stigma or social inﬂuences should be dealt with
creatively to optimize the behaviour support for sustainability and scale-up.
npj Primary Care Respiratory Medicine           (2019) 29:34 ; https://doi.org/10.1038/s41533-019-0146-6
INTRODUCTION
Tuberculosis (TB) is a major global burden of disease, with 10
million people developing TB disease and an estimated 1.3 million
deaths from TB in human immunodeﬁciency virus-negative
persons in 2017.1 Of these cases, 87% occurred in high TB burden
countries in Asia and Africa, with Pakistan and Bangladesh among
the 8 countries with the highest numbers of cases.1 Pakistan
accounts for 61% of the TB burden in the World Health
Organization Eastern Mediterranean Region with 510,000 new
TB cases yearly.2 In 2017, >360,000 new TB cases occurred in
Bangladesh.1 TB is linked to tobacco smoking, and an estimated
15–20% of all pulmonary TB cases are associated with tobacco
use.3 Tobacco smoking increases risks of a TB infection and
worsens its prognosis through increased severity of symptoms,
such as cavity lesions, continued increased likelihood of positive
sputum and culture, decreased treatment adherence and
increased risk of death.3–5
In Pakistan, tobacco use prevalence is estimated at 32% for men
and 6% for women.6 In Bangladesh, male smoking prevalence
remains at >30%, whereas women are perceived to rarely smoke
yet do use smokeless tobacco products.7 It is projected that up to
18 million excess TB cases and 40 million excess deaths from TB
could occur between 2010 and 2050 should smoking rates
continue along their current trajectory.8 Persons with TB can
therefore beneﬁt from tobacco cessation support, especially
considering that many immunological abnormalities in TB patients
induced by tobacco smoking might reverse within 6 weeks of
quitting.9 The TB diagnosis is a “teachable moment”10 to motivate
people to re-assess their smoking behaviour, but standardized
tobacco cessation is not yet widely offered in routine TB care in all
high-burden TB countries. “TB & Tobacco”, a European Union-
funded consortium, used an effectiveness-implementation hybrid
design to study precisely this teachable moment by implementing
a behavioural support intervention within TB care in Bangladesh
and Pakistan. This occurs alongside a large randomized controlled
trial to assess the effectiveness of cytisine (active vs. placebo).11
A brief behaviour support intervention was developed and
tested with patients and health workers, consisting of a ﬂip book, a
leaﬂet and a poster.12 Materials can be downloaded for free on the
project website https://tbandtobacco.org/. The key messages relate
to managing TB and to quitting tobacco use, based on behaviour
change techniques (BCTs) found effective in tobacco cessation
interventions.13,14 Health workers received training in delivering the
15–20min long intervention, focussing on tobacco use facts and on
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soft skills for communication and rapport-building with patients.12
At these trainings, health workers were also asked if they used
tobacco themselves as part of a COM-B15 assessment pre- and post-
training. The vast majority of health workers said they did not
smoke (100% in Pakistan and 95% in Bangladesh).
Considering the high potential health gains for TB patients if
offered smoking cessation, it is worth exploring the way our
intervention was integrated into routine care and how health
workers and patients perceived its acceptability, effectiveness and
added value. What were the implementation processes at the
clinic level in Pakistan and Bangladesh, and which barriers and
facilitators to implementation on the ground might need
addressing before country-wide scale-up? To answer these
research questions, we conducted a process evaluation at three
TB clinics in Pakistan and two TB clinics in Bangladesh. This paper
reports ﬁndings on patient and health worker views regarding
mechanisms of interactions between health workers, patients and
the intervention and facilitators and barriers to successful
integration of the intervention into routine TB care.
RESULTS
Selected study sites
Out of 17 trial sites in Bangladesh and 14 trial sites in Pakistan, a total
of 5 clinics were included as study sites. These included two case
study sites per country where data were collected from patients and
health workers and an additional ﬁfth site in Pakistan where only
health worker interviews were conducted. This site had originally
been intended as a full case study site, but following low patient
recruitment into the trial as many patients here had diagnoses of
extra-pulmonary TB and were thus ineligible for recruitment, the site
was closed and the case study shifted to another site to allow for full
data collection including patient interviews. Characteristics of these
case study clinics are described in Table 1.
Provision of behaviour support: health worker views
We interviewed six health workers in Pakistan and two in
Bangladesh, three women and ﬁve men (sample is described in
Table 2). They ranged in age from 23 to 60 years and had been
working with TB patients between 1 and 20 years; all were
responsible for providing the behaviour support sessions. Their
feedback on the intervention was generally positive, and they saw
a need to offer smoking cessation support to their TB patients.
Findings are reported by Consolidated Framework for Implemen-
tation Research (CFIR) construct for the health workers. Presented
are those constructs that appeared frequently in the interview
coding or that corresponded closely to our core research
questions on how health workers interacted with the intervention
and with their patients. Respondent DF4 was stationed at the
clinic that was dropped at a case study site due to low patient
enrolment into the trial, but behaviour support was implemented
at this site and interviews with this health worker conducted.
CFIR construct: Patient Needs and Resources
Health workers’ responses focussed frequently on patients’ needs
and resources and whether the materials were useful to patients:
“Like I told you before ﬂipbook is a better tool
because when we are counselling a patient,
what we say is not that effective but what we
show with the help of pictures, for example
when we tell them that if you smoke along
with TB, your recovery will be slow and like Ta
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that. Then the patient gets involved in pictures
and listens carefully and pays more attention
during counselling.”
DF4, f, 29, Pakistan
Health workers adapted their delivery as needed speciﬁcally for
patients with less formal education or who were unable to read
and write:
“[…] I altered the chart a bit; I consider that
matter - whether the patients would be able to
pay that much attention or not; so I have
removed some part of the material; as well as
marked some important part of it.”
DF7, m, 60, Bangladesh
They were aware, however, that their efforts had limits and that
the ultimate decision to quit was still the patients’ to make:
“It is our effort that people should quit… we
can only tell the patients that it is harmful…
what else?”
DF2, m, 45, Pakistan
CFIR constructs: Self-Efﬁcacy and Culture
The constructs of patient needs and resources overlapped with
culture and self-efﬁcacy in health worker statements: Asking
women about smoking required that health workers felt capable
of broaching this topic with the opposite gender, they expressed
awareness of different educational and ethnic backgrounds
among their patients and tailored their messaging accordingly,
and adapted their approach to account for restraints stemming
from patients’ fatigue or lack of time. For some health workers,
approaching patients of the opposite sex regarding their smoking
habits was more challenging than for others:
“We cannot ask this directly. If we do, we will
immediately receive a slap from her. (laughs)
And she will say: ‘Don’t you feel ashamed of
talking about cigarette with me? Are you
joking? I am like your sister/mother.’ Such
things start happening and one feels embar-
rassed in situations like these. But I directly
rotate such situations and tell them: It is our
responsibility and duty to ask you if you are
having any problem other than that.”
DF3, m, 31, Pakistan
If patients were found reluctant to disclose their smoking habits,
health workers looked for some privacy to enquire about such
questions:
“Most patients tell us …teenagers who have
hidden it from parents are reluctant to disclose
in front of parents but we can see from their
expression that they want to disclose but can’t
so we provide them privacy and they tell us.”
DF6, m, 29, Pakistan
In Bangladesh, health workers stressed the opportunity to save
money spent on cigarettes for food for the family. Other cultural
aspects included how to respectfully address patients, dealing
with patients crowding the counselling room for fear of missing
out on important information, and power relations between
patients and health workers.
CFIR constructs: Structural Characteristics and Costs
While the health workers were highly motivated and convinced of
the relative advantages of the intervention, they had to deal with
structural barriers to its implementation. These included high
patient volume, infrastructure not conducive to counselling in
private, high administrative workload and many patients not
Table 2. Health worker sample characteristics
Health worker Age Gender Education Time worked with TB patients Country Site
DF1 31 Male M.A. in Education 10 years Pakistan Site 1
DF2 45 Male Intermediate 20 years Pakistan Site 1
DF3 23 Female B.A. 11 months Pakistan Site 1
DF4 29 Female M.A. in Sociology 5 years Pakistan Site 3
DF5 40 Male Intermediate 19 years Pakistan Site 2
DF6 29 Male B.A. in Library and Information Sciences 9 years Pakistan Site 2
DF7 Late 50s Male Tuberculosis and leprosy control assistant degree 5 years at this site Bangladesh Site 5
DF8 52 Female Paramedic 4 years at this site Bangladesh Site 4
TB tuberculosis
M. Boeckmann et al.
3
Published in partnership with Primary Care Respiratory Society UK npj Primary Care Respiratory Medicine (2019)    34 
returning for follow-ups. The costs of implementation were
therefore mainly health workers’ time and efforts, which caused
problems of prioritization:
“When I have to call the patient for ﬂip book a
lot of my time is taken up and my work starts
piling up….while I am busy with ﬂip book…
number of waiting patients starts increas-
ing….sometimes even to 14…some people are
attracted and start listening…ﬂip book is time
consuming even though it is beneﬁcial.”
DF1, m, 31, Pakistan
The health workers requested support in dealing with the
administrative tasks to free them up for counselling and to
consider further reducing the number of pages and messages in
the ﬂip book:
“So, the thing that we usually do in 5–10 min
takes us 20–25 min. Let’s suppose we explain
TB01 and TB02 card, what we can do is we can
probably join 4-5 messages on TB02 card
somehow.”
DF5, m, 40, Pakistan
Patient feedback on the behaviour support and intervention
materials
A total of 35 patients participated in the interviews, with 4 from
Pakistan and 3 from Bangladesh agreeing only to the ﬁrst round of
interviews (see Table 3 for description of the patient sample).
Thirty-four of these interviewees were men. The participants’ ages
ranged between 18 and 60 years, with a majority with low or
modest incomes and some with limited formal education.
Findings are presented by Theoretical Domains Framework (TDF)
constructs that were frequently identiﬁed in the interviews or that
answered the research question on patients’ smoking behaviour
after the intervention. We observed similar responses to the
questions on satisfaction with the intervention across the patient
sample.
TDF construct: Behavioural regulation and breaking habits
The participants frequently reported making quit attempts and
changing their smoking behaviour; many linking their willingness
to quit with their TB:
“It was a nice explanation that health worker
gave. The way he spoke to me, all the words
matched with my heart and soul that I
realized, it is better to give up. I felt pity for
myself as I have become very feeble. My
disease increased due to smoking, for that I
also had plans to give up. Now, I have given
up smoking and it is been a week since I totally
got rid of smoking.”
P30, m, 25 years old, Bangladesh
The potential effect on other family members in case the
breadwinner remains sick or even dies was also a motivator to quit
smoking:
“I think it came from understanding the
importance of staying alive. I am ill. And if I do
not recover then how will my family function.
Furthermore, I will not survive. So it was from
that realization that I decided to stop. If
anything happens to me then my children and
family will suffer. I will not exist and they will
suffer. This is mainly why I quit smoking.”
P22, m, 40, Bangladesh
While support from the health workers was perceived to be an
eye-opener to the importance of quitting, the majority of
participants felt that their quit success relies on their willpower:
“Smoking… it’s not good. What I’m doing is
not legal, not right. I also know that it’s not
Table 3. Patient sample characteristics
Characteristics Pakistan Bangladesh Total
Total 18 17 35
Gender
Female 1 0 1
Male 17 17 34
Age, in years
18–25 3 6 9
26–35 6 6 12
36–45 2 2 4
46–55 7 1 8
56–65 0 2 2
Occupation
Unemployed 3 2 5
Manual labour 4 4 8
Driver/taxi driver 5 0 5
Businessman or employeda 3 11 14
Teacher/preacher/ofﬁce worker 3 0 3
aEmployed= any other job held as employee (not self-employed, none of
the other categories listed here)
M. Boeckmann et al.
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good, but I did. […] It’s all about our heart,
how we feel and act. It’s up to us if we want to
quit or not. I quit smoking earlier as well, like
during Ramadan I didn’t have cigarettes. I quit
smoking for the sake of fasting, didn’t break a
single fast! Kept the spirit up for one month; 30
long days of fasting, yet I started again. My
weakness got me again. It’s all in the brain,
nothing else. Just the brain got into evil spirit
again.”
P26, m, 40, Bangladesh
In Bangladesh, the chance to save money by quitting was also a
common reason given for making quit attempts:
“I stopped all by myself as it’s difﬁcult to go to
relatives, children, wife. They also have a
future. It costs 200 to 150 taka to smoke.
Instead, if I eat actual food like rice curry with
my wife and kids, it’s far better.”
P23, m, 25, Bangladesh
A few patients reported “cutting down to quit” as a preferred
option rather than setting a quit date and following the “not a
puff” rule. “Not a puff” means committing to quitting abruptly and
to not smoking at all to avoid continued nicotine exposure:
“Yes, I am trying. It is quite better than before. I
am trying a lot.
I [Interviewer]:
What do you mean by saying ‘trying’?
P20:
What? Before if it was 5 now it is 1 or 2. That is
how you can stop but it will need a bit of time.
You cannot leave it at once.”
P20, m, 18, Bangladesh
Dealing with cravings was an important topic of conversations.
The majority adhered to professional advice on substituting
smoking with another habit such as taking lozenges, asking
friends and family for support or distracting oneself to deal with
cravings and withdrawal symptoms. Others ranged from avoiding
all social contact and staying indoors to physically breaking other
people’s cigarettes when they smoked in front of the patient:
“I:
When you had the craving for a cigarette, how
were you able to resist that?
P32:
When I had cravings, I did not go near
cigarettes. I did not even go near to any shop. I
remained seated in my home all the time. I did
not go outside at the time of craving; rather I
remained in my home, continuously.”
P32, m, 24, Bangladesh
“I just keep on asking [my family member] to
quit. What else do I have to feel? If he smokes
around me and if I get hold of his cigarette, I
just break it.”
P9, m, 50, Pakistan
Overall, behavioural regulation was connected to beliefs in
one’s capabilities, beliefs about consequences and social
inﬂuences.
TDF constructs: Social and Environmental inﬂuences
The three social groups mentioned in connection to smoking were
family, friends and work colleagues. Social environments rather
than physical environments mattered to patients’ narratives:
“My mother was very upset with me due to my
smoking habit…they all do try to keep me
from smoking.”
P13, m, 35, Pakistan
M. Boeckmann et al.
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“It was just yesterday that a friend of mine was
offering me a paan. He said one paan will not
make any difference. But I told him: ‘No, I have
quit’. So, I did not have it.”
P5, m, 34, Pakistan
TDF construct: Beliefs about consequences
Offering cytisine together with behaviour support was seen as a
successful approach by patients:
“To get rid of this habit, this medicine helps
you completely. You have to make a decision
for yourself, of course, but the capsules that I
got from RA [research assistant] help a lot in
this.”
P7, m, 52, Pakistan
Social groups strongly inﬂuenced behavioural regulation and
person/environment interaction. Family support was the most
frequently cited contributor for quit success besides willpower,
and pressures from work colleagues and friends to keep smoking
were barriers to cessation.
Beliefs about consequences were linked to quitting, failing to
quit and to the consequences of receiving cytisine. Quitting
smoking was identiﬁed to have multiple beneﬁts for one’s own
health and for one’s family:
“I told them that they did this for my own
good. The money I spent on smoking, I will buy
milk for you with that instead. That way, my
health will stay better. That was harming me. I
understood that I am better after I quit
smoking.”
P23, m, 25, Bangladesh
“I:
Why do you think that it was better to quit
smoking?
P26:
I smoke now but when I gave up smoking, I
gained weight. I have a child, I have to feed
him/her, and my child can be affected though
I told them that I do not smoke now.”
P26, m, 40, Bangladesh
A large number of patients reported that they believed the
medication helped them quit, even when it was uncertain
whether they had received cytisine or placebo.
“I:
Can you please elaborate on your experience
of quitting smoking?
P28:
After consuming the drugs, a strange thing
happened. When the smell of cigarettes
entered my nose I felt like vomiting. I simply
cannot tolerate the smell now. Not at all. I was
surprised to see this change in me which
happened after I quit smoking and had the
drugs.”
P28, m, 27, Bangladesh
TDF construct: Emotion
Although the original TDF construct Emotions focusses on
negative emotions, we decided to include positive feelings in its
description for our project. Stigma and shame about being
confronted about one’s smoking habit were also coded with this
construct. While many patients in Bangladesh did not keep their
smoking habits a secret, their TB diagnosis was often a delicate
matter:
“I:
That’s good. Did you talk about quitting
tobacco with your family or friends after the
session at the hospital?
P23:
M. Boeckmann et al.
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No, I didn’t talk to them about this [TB].
I:
Nobody knows?
P23:
No.
I:
Then what do they do?
P23:
If they knew, they will not be communicating
with me, they’ll stay away from me. That’s why
I didn’t tell them.”
P23, m, 25, Bangladesh
Among Pakistani respondents, tobacco use was perceived as
more illegitimate than among the Bangladeshi participants,
although the majority of respondents expressed that they were
not embarrassed about admitting to smoking:
“No No No…it was very easy for me to talk
about it. My parents, wife and ﬁve kids live in
village. It’s not that they will write something
about smoking in my ﬁle and they will beat
me up. I live alone so I am not afraid of
anyone. It is my decision.”
P10, m, 30, Pakistan
As expected, the sole female interviewee in Pakistan expressed
strong concern about societal and familial reaction to the
discovery of her smoking habit:
“If I smoke cigarettes and hookah, I do it
keeping it hidden from my father because if he
knows about it, he would beat me. It is not
allowed in my family. So, when they were
talking to me about quitting intoxications and
all, were all surprising for me. They were
saying that they would give me a treatment
but I was feeling startled about it.”
P15, f, 25, Pakistan
Emotions were also associated with giving up smoking, some
very positive but some with a little regret:
“I felt irritated and felt like something was
missing, there was an emptiness all the time.
There was a lack of something that I always
used to have. Like this, something felt gone.”
P28, m, 27, Bangladesh
While emotions were expressed as part of participants’
reactions to the intervention, they were not portrayed as a major
barrier or facilitator to cessation.
Emerging constructs: Perceptions of the intervention process and
of the TB diagnosis and therapy process
Patients remembered the counselling sessions and expressed
gratitude to be given advice and support. None of the patients
had suggestions for changes to the intervention nor did they
criticize what we perceived as shortcomings, such as lack of
private rooms for counselling, infrastructure age and state, long
wait times or being asked directly about smoking habits.
The advice given by health workers was appreciated:
“Bhai [a polite way to address a male person
in Urdu; meant to mean the health worker]
told me many things, made me understand.
Umm… he gave me medicines. […] He told
me that smoking is bad, bad for health. It
creates problems, for me, for the people
around me, for everything. Mostly it makes me
sick. It’s not good for health. And the money I
spend on smoking is basically wastage of
money. […] He made me understand that I
can save this money for some other need or
necessity. I may buy fruit and have it instead of
cigarettes, or may be something nice for my
kids, why waste it on smoking? These are the
things he told me and made me understand.”
P26, m, 40, Bangladesh
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Narratives of the long process from ﬁrst TB symptoms until
diagnosis and referral to the health workers indicated stressors for
patients that were not directly linked to the intervention.
Emerging code: Religious beliefs
Expressions of faith are part of communicative rules in both
Bangladesh and Pakistan. In some instances, beliefs in capabilities
to quit were linked to support from God:
“I:
That’s good, how do you feel about quitting
smoking now?
P21:
Yes, a bit difﬁcult but better now. Inshallah. If
Allah wants I’ll continue like this. I am coping
with all.”
P21, m, 60, Bangladesh
Similarly, the expectation whether or not one can be cured of
TB was linked to faith:
“P23:
Everyone at home knows.
I:
Can you please explain a bit?
P23:
I informed them, told them about my disease,
medicine, smoking, quitting. What else would
they say? They are just crying. I told them
what’s the point? Only Allah grants us the
permission to live and die.”
P23, m, 25, Bangladesh
Cross-country differences in patient experiences
Faith was expressed more often in the Pakistan sample,
particularly in relation to willpower to quit cigarettes and
regarding beliefs about whether TB will be cured. In Bangladesh,
patients more frequently listed money as a beneﬁt of tobacco
cessation, which is likely linked to the Bangladesh intervention
materials that, other than the Pakistan materials, included money
as one additional aspect. All male participants reported less stigma
related to tobacco smoking than expected, although some
discomfort upon being asked about their smoking was expressed
in their responses. Health workers were partly concerned about
asking patients directly if they smoke, which is a discrepancy to
patients’ views.
DISCUSSION
The TB & Tobacco behaviour support intervention for tobacco
cessation for TB patients was largely successfully implemented in
routine TB care at four case studies in Bangladesh and Pakistan,
while one case study site had to be dropped due to low
recruitment.
This study provided insights into the realities of offering a
smoking cessation behaviour support intervention in TB clinics in
Bangladesh and Pakistan and, to our knowledge, is one of few
qualitative studies reporting the process evaluation of a multi-
country smoking cessation implementation study in patients with
TB, collecting both patient and health worker perspectives at
multiple time points. Based on constructs identiﬁed in the
interview analyses, our ﬁndings suggest that the following aspects
of the behaviour support intervention were perceived as useful by
health workers and patients:
● Targeting the TB diagnosis as a teachable moment for tobacco
cessation: Patients reported that learning about the impacts of
smoking on TB progression was a motivating factor for
quitting.
● Having picture-heavy materials available to illustrate mes-
sages: Health workers felt comfortable showing pictures to
patients and assumed these would aid in understanding the
main messages.
● Providing relatable reasons for cessation such as health,
family, saving money to afford essentials: Patients reported
that social situations with friends, family or at the workplace
inﬂuenced their smoking behaviour.
These ﬁndings on the importance of images are in line with
prior research on BCT-based cessation interventions in South
Asia.16–18 Patients were not opposed to being approached about
their smoking habit, although health workers expressed concerns
that women might not admit to tobacco use and that asking
about tobacco use was a sensitive issue.12 There is a need for
more in-depth research on what role stigma really plays and
whether gender remains a determinant for smoking even among
younger generations of women in Bangladesh and Pakistan.19–21
We cannot be sure to what degree our anticipation of hesitancy in
admitting use might have been part of our training and our
interaction with the participants and hence shaped their
responses more than actual concerns.
Interviewed patients predominantly stated they had made
successful quit attempts 4–6 weeks after being counselled.
Similarly to ﬁndings from high-income contexts, social environ-
ments played an important role in dealing with cravings and
withdrawal symptoms,22,23 and a strong belief in willpower has
also been described in tobacco cessation research in Western
countries and in Oceania.24–26 The role of religious convictions in
supporting cessation attempts was not a targeted aspect in the
intervention or process evaluation, but other studies are
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investigating this phenomenon27,28 and it could be considered for
future adaptations of the programme.
Structurally, health workers were highly motivated to support
their patients to quit smoking, yet they were burdened with
administrative tasks, shifts among colleagues, high patient
volumes and lack of acknowledgement of their accomplishments
at some clinics. While the intervention is designed to be
integrated into counselling that already takes place, in reality
work routines were not always conducive to such changes and
caused additional time burdens. To address these challenges,
support from National TB Programmes and clinic heads to reduce
documentation burden and ensure regular refresher training
seems to be essential, as has been shown elsewhere.18
Patients and health workers problematized the following
aspects of the intervention process:
● Being willing to admit to smoking at all depends on the
individual patient’s comfort level: Health workers felt a need to
make sure there was privacy and trust before asking patients
directly about their smoking habits. This was especially the
case for male health workers asking female patients.
● Adding the counselling process to the diagnosis and TB
counselling often requires more time than the health workers
feel they have available: The duration of the intervention was
discussed frequently.
Overall, the intervention appears to address a need at clinics
and was welcomed by participants.
Throughout this qualitative process evaluation, different levels
of power relations played a role: between researchers and
respondents, patients and health workers, and health workers
and their employers. Interviewers in Pakistan and Bangladesh as
well as the data analysts were members of the TB & Tobacco
research consortium and were invested in the success of the
project. Their status as researchers and doctors likely also
inﬂuenced how respondents reacted to them, particularly related
to the gap in social status between the patients and the
interviewers. Our interviewers were all female; almost all patients
interviewed and the majority of health workers were male. This
added another layer of power differentiation to the interview
situation.
As this study was conducted as part of a pragmatic clinical trial
in lower-resource settings, some limitations occurred during data
collection and analysis. Several round two patient interviews were
conducted by phone rather than face-to-face, in cases where the
patients did not return to the clinics as expected. Patients were
asked to be interviewed on the day they received their TB
diagnosis. They were often tired, had already been at the clinic for
a long time and were weak from their illness. As a result, the
sampling approach had to be pragmatic as fewer patients were
willing to talk to us. Gender bias in both countries also greatly
reduced our opportunities to interview women. In addition, as
interviews had to take place at the clinics to avoid further time
burden or risk exposing patients’ illness to their social environ-
ments by interviewing them at their homes or work places, the
interview situation was characterized by noisy surroundings, lack
of complete privacy and potential interruptions. Interviewees may
not have been completely open during these interviews if other
patients or health workers were nearby. In Pakistan, patients were
interviewed in rooms a bit further away from the health workers to
ensure as much privacy as possible. In some instances, a male
research assistant accompanied the female interviewer if the
interviewee was male and the interview location a more isolated
room. Patients were also interviewed while receiving TB treat-
ment. It is possible that they worried about quality of their care, or
felt indebted to the researchers in a way, and thus possibly gave
socially desirable answers. While health workers were given the
option to be interviewed in a different setting, they preferred their
work places to save time and be in a familiar environment. Site
number 3 had to be dropped as a case study site due to the trial
requirements. While BS implementation occurred and interviews
with the health worker at this site were conducted, we were
unable to get patients’ viewpoints on the process at this clinic.
Owing to staff re-organization, some follow-up interviews with
patients or health workers were conducted by a different
interviewer, which could have inﬂuenced willingness to respond.
We examined the possibility of social desirability by looking at
both interviews taking place face-to-face at clinics and those
conducted via phone to assess whether there are discernible
differences in patient views on the intervention. We found neither
large discrepancies between the two groups outside of the
expected difference between individuals’ perceptions nor any
patterns of satisfaction or dissatisfaction.
All interviews were conducted in the interviewees’ and
interviewers’ native languages, then transcribed by bilingual
speakers directly into English. While this enabled a multi-
professional and multi-national analysis process, we cannot rule
out translation errors or errors in ascribed meanings. To counter
this problem, all analysis occurred either in a cross-country team
or, as with the Bangladesh data set, country teams gave feedback
on coded text segments. We chose a case study approach to
conduct in-depth research at selected clinics to gain insights into
practices on the ground and in the “real world”. This approach was
a good ﬁt for the research question of how the implementation of
the behaviour support intervention was perceived. Different
project work packages, such as a quantitative process evaluation
component and the context evaluation, will help ﬁll in potential
gaps left by this interview study.29
These stated limitations give good insights into implementation
challenges at the clinic level: issues of lack of privacy, noise levels,
or patients not returning for follow-ups are equally relevant for the
intervention implementation and scale-up. Our limitations thus
highlight areas of particular concern for future iterations of the
behaviour support programme. On the other hand, this study has
multiple strengths. All research was conducted by multidisciplin-
ary teams from Europe and from Pakistan and Bangladesh who
were equal members of the research consortium. Local expertise
was essential to the success of the interview study. Having
interviewers from the project team who had previous working
relationships with the clinics provided a level of familiarity and
trust that made it possible for the health workers to open up
about their experiences. We collected qualitative data from
different perspectives and at different time points, which is
unusual for trial process evaluations and adds value. Having
longitudinal interview data from both patients and health workers
allowed us to better understand how the intervention was
integrated into routine care in the medium term and how
patients interacted with the knowledge and skills provided during
the counselling after they left the clinic. As the interviewers not
only visited the clinics for the interviews but also frequently for
other tasks related to the trial, they were able to gain further
insights into mechanisms at the clinics and to become a more
accepted presence at sites. Interviewers were culturally and
socially familiar with contexts at sites and spoke participants’
languages. Interviews were coded by two coders (Pakistan) or by
one coder with coding discussions with the larger team
(Bangladesh) to include multiple perspectives in the interpretation
of ﬁndings.
We triangulated the interview data with health worker notes on
non-participation, ﬁeld notes accounting direct observation of
researchers from site visits and with feedback from other project
researchers who were not part of the qualitative assessment yet
were deeply involved in other aspects of the study. This added
validity to our data and provided a more comprehensive picture of
the implementation status at sites.
Most frequently raised points include that intervention materi-
als appeal to patients and health workers and the TB diagnosis is a
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teachable moment that can be harnessed for cessation support.
However, high workloads for health workers in the TB clinics,
stigmata regarding women who smoke and social inﬂuences on
smoking behaviour remain challenges that need to be dealt with
creatively for sustainable scale-up and long-term implementation.
METHODS
Details of the behaviour support intervention, the cytisine trial and the
process evaluation are published in the process evaluation and the trial
protocols.11,29 In short, regarding the behaviour support intervention, we
aimed to systematically assess the implementation process at clinic level
and to discover mechanisms of interaction between participants and the
intervention by observing and interviewing patients and health workers.
For the qualitative process evaluation components, we chose a multi-site
case study design30,31 to gain an understanding of the multi-faceted and
complex real-life contexts at the clinic level. In deviation from the protocol,
the qualitative ﬁndings are reported here separately from the quantitative
ﬁndings, as the trial was delayed yet behaviour support implementation
had started in 2017.
Study site selection reﬂected key dimensions of difference among
facilities in each country. We included clinics from varying healthcare levels
(primary, secondary or tertiary), different staff size, and from both urban,
peri-urban and rural settings. Selection also accounted for site conditions
regarding work ﬂows and willingness of clinic heads and staff to
participate in the study. We only included sites that had medium-to-high
patient ﬂow to ensure adequate interview participant sample sizes among
patients.
Data collection
To assess intervention implementation, semi-structured interviews (SSIs)
were conducted with health workers from ﬁve case study sites and with
patients from four sites (see section on “Interviewee sampling” below). The
interview guides (see Supplementary Files 1 and 2) were developed during
the ﬁrst phase of the study in a larger team consisting of researchers from
the UK, Czech Republic, Germany, Pakistan, Bangladesh and Nepal. Guides
were written in English, translated into Urdu and Bangla by native speakers
and translations checked against original English versions. Interview guides
covered contextual, implementation and interaction aspects (Table 4). The
Pakistani interviewers (M.N., R.Z.) wrote memos on the interview situations
that were used as contextual data to support the analyses. One of the four
interviewers (M.N.) was also involved in data analysis.
Study participants: sampling for interviews
Health worker sampling approach. At each case study site, all health
workers predominantly in charge of providing directly observed treatment
short course for TB were trained in March 2017 to deliver the behaviour
support session as part of their routine counselling. These health workers
were invited to be interviewed at three different time points over a period
of 11 months to examine the development of intervention implementa-
tion. We opted for a longer data collection phase to capture health
workers’ views early in the implementation process, in the middle and
towards the end of the study. This allowed us to assess whether attitudes
and practices changed over the project duration, after health workers
became more familiar with the counselling process and the project was
integrated into clinic routines. In Pakistan, ﬁve health workers (pseudo-
nyms: DF1, DF2, DF4, DF5, DF6) from three sites were interviewed at
baseline (July to September 2017), four (DFs 1, 2, 4, 5) at the second time
point (December 2017) and four (DFs 1, 3, 4, 5) at round 3 (April to May
2018) for a total of six different interviewees. None of the trained health
workers refused to be interviewed. The sample size between interview
rounds differed owing to health worker re-assignments. One preliminary
case study (Site 3) was removed from the trial due to low patient
recruitment, necessitating cessation of patient interviews at the site. A new
case study site (Site 2) was initiated, subsequently leading to new interview
partners among the health workers. In Bangladesh, the same two health
workers from two sites were interviewed three times (baseline: October
2017; second round: January 2018; third round: May 2018). Interviews with
health workers were conducted at their work place to allow participation
without asking them to take unpaid time off.
Patient sampling approach. Patients enrolled in TB care, who had agreed
to participate in our study at the case study sites, were purposefully
sampled. They were approached face-to-face after leaving the consultation
with the TB health worker and were invited to participate in two SSIs.
Patients approached to be interviewed had to have received the behaviour
support counselling, be enrolled in the trial and be able to give consent.
Those who refused to participate did so mainly on grounds of lack of time.
The purposeful sampling approach was pragmatic and aimed to capture a
range of voices to identify how different people interacted with the
intervention and to hear their input on possible intervention changes. We
estimated that a sample of 5–10 interviews per case study site32 would be
a realistic goal to hear perspectives from different age groups, occupa-
tional and educational backgrounds and smoking histories required for the
narrow scope of the research question.33,34 Our sample size was
determined using Malterud et al.’s concept of “information power”34 for
qualitative research, which ensures information maximization for smaller
study samples by thinking through ﬁve domains. In our research, four
domains suggested a smaller sample size given (a) the narrowly deﬁned
aim to identify facility-level implementation barriers and enablers, (b) a
speciﬁed sampling of participants to represent a cross-section across
facilities and time points, (c) application of CFIR and TDF theoretical
frameworks to data collection and analysis, and (d) incisive and in-depth
dialogue between researchers and participants. The ﬁnal domain of having
a cross-case analysis strategy for interviews suggested widening the
sample size to ensure a representative sample across the facilities and
countries.
Owing to the gendered nature of smoking in Bangladesh and
Pakistan,7,35 women rarely stated using tobacco and were not willing to
be interviewed on this topic, with one exception in Pakistan. While a
private interview situation was sought, at the sites a private room was
rarely available, and some patients asked for spouses or family members to
stay present during the interview.
The two interviewers in each country (M.N., R.Z., F.F., E.H.M.) were
members of the core TB & Tobacco research team and were involved in
several study work packages in addition to the process evaluation. All
interviewers had previous research and academic experience, were trained
in conducting SSIs and were ﬂuent in their native languages and in English.
Consent procedures. Participants’ written consent was received prior to
data collection. Consent forms were adaptable for illiterate patients as they
allowed signature by thumbprints if needed. Selected patients who were
no longer returning to the site for medication pick-up or were otherwise
physically unavailable but who indicated willingness to participate in
follow-up interview rounds were interviewed by phone. In these cases,
verbal consent was taken over the phone and recorded, and written
consent provided at the next trial follow-up appointment after the
interview.
Table 4. Interview topics
Topics included in health worker interview guides Topics included in patient interview guides
•Perceptions on intervention materials
•Perceptions on delivering the behaviour support intervention
•Further training and support needs
•Interactions with patients
•Recommendations for future programme adaptations
•Patients’ experience of behaviour support received
•Perceptions of intervention materials
•Family and friends’ tobacco habits
•Tobacco rules at patients’ work places
•TB medication and tobacco cessation regimens burden
•Social support for quitting tobacco and potential stigma
•Tobacco availability near the clinic, patients’ houses and work place
•Recommendations for future programme iterations
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Ethics approval. Ethical approval for all aspects of the qualitative data
collection was gained for all sites (University of Leeds (MREC15-063),
Bangladesh Medical Research Council and Bangladesh Drug Administra-
tion (BMRC/NREC/2016-2019/1475), Pakistan Medical Research Council (4-
87/16/NBC-200 Part-B/RDC/4/97)).
Data analysis
Interview analyses. Interviews were audio-recorded, transcribed directly
into English from Urdu or Bangla and analysed using a combined
deductive and inductive approach based on the CFIR36 and the TDF.37,38
This tailored framework approach was used to capture organizational
aspects of implementation as well as individual voices. CFIR has been used
to analyse and evaluate complex interventions in lower-income settings39
and focusses on factors relevant to implementation success across ﬁve
domains: intervention characteristics, outer setting, inner setting, char-
acteristics of individuals, and process. As CFIR focusses strongly on
implementation at an organizational level, TDF was used to capture patient
voices as it includes constructs such as emotion that are missing from CFIR.
Each country data set was coded separately and then combined to
explore cross-country similarities and differences. Among the authors, M.B.
from Germany and M.N., who conducted the majority of interviews in
Pakistan, analysed the Pakistan data set together with Esther Scholz, who
was not involved in the study. The Bangladesh data set was coded by M.B.,
with discussion on selected coded sections with a multi-professional team
of the TB & Tobacco consortium. This means that, in the Pakistan data set,
all interview transcripts were coded by two researchers independently. In
the Bangladesh data set, all transcripts were coded by one researcher and
ﬁndings presented and discussed to a group within the research team.
Health worker and patient interviews were analysed by country, using
the NVivo 11 Pro and MaxQDA 11 software, as separate sets. Health worker
interviews were coded in two rounds, ﬁrst employing only the CFIR
framework, and then identifying and applying emerging constructs.
Similarly, the ﬁrst round of patient interviews only used TDF constructs,
with emerging codes added and used in the second round. See
Supplementary Files 3 and 4 for the codebooks. Summary memos were
developed for each case study site containing the primary identiﬁed
constructs with supporting quotations from health workers and patients.
Owing to patient ﬂuctuation at the sites, shortage of time among
patients and health workers and high illiteracy among patients, we were
unable to return transcripts to participants for checking. We thus relied on
feedback from the research teams to verify ﬁndings from transcripts.
Members of the research teams spent signiﬁcant time at the sites during
the trial and implementation period and were presented with coded
sections and ﬁndings during the analysis process.
Reporting summary
Further information on research design is available in the Nature Research
Reporting Summary linked to this article.
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